The Facts
Costs from poor medication adherence are estimated to exceed $100 billion annually.
Section 2713 of the Affordable Care Act implements value-based insurance design by giving patients access to primary prevention services recommended by the United States Preventive Services Task Force (USPSTF). The Administration has issued an interm final rule (IFR) implementing Section 2713, as well as a request for information (RFI) exploring the concept of value-based insurance design in federal policy. The 2011 National Prevention Strategy also cited Section 2713 and innovative health benefits designs as effective tools to increase preventive care options to Americans.
On September 17, 2010 the V-BID Center responding to the IFR on preventive care (implementing Section 2713 of PPACA). The comments strongly endorse the design of the preventive care benefit outlined by HHS, which embodies the concept of V-BID by using clinical evidence to match populations with recommended medical care. The letter also expressed hope that V-BID will be applied beyond primary prevention to secondary prevention where it has been demonstrated to enhance health and contain costs.
An amendment to the IFR was issued on August 3, 2011 extending coverage without cost-sharing to certain women’s primary preventive services, based on recommendations from the Institute of Medicine.
> Read the Center's Comments on the IFR for Section 2713
> Read IFR August 3 Amendment
> Read the Center’s comment letter on the IFR amendment for women's preventive services
On December 28, 2010 the Departments of Labor, Health and Human Services and Treasury issued a Request for Information (RFI) on V-BID and preventive care. This request sought detailed information on V-BID programs in relation to the current health reform legislation addressing preventive care (Section 2713). The Center issued its response to the RFI on February 28, 2011. This response reflects a collaborative effort of the Center with a wide range of stakeholders who contributed feedback and information crucial to shaping Federal Departments' perspective on V-BID implementation.
> Cover letter of Center's Response
> Center's Response: Questions and Answers
Costs from poor medication adherence are estimated to exceed $100 billion annually.
“The V-BID Program is not just a drug design, but we are putting our arms around the total health care spend and return.”
- Bill Bruning
President and CEO
MACHC